ImaLife
Imaging in Lifelines...
Description
Lung cancer, chronic obstructive pulmonary disease (COPD), and coronary artery disease (CAD) are expected to cause most deaths by 2050. State-of-the-art computed tomography (CT) allows early detection of lung cancer and simultaneous evaluation of ima...
General Design
- Type
- Cohort study
- Cohort type
- Population cohort
- Data collection type
- Prospective
- Design
- Longitudinal
- Design schematic
- Design schematic
- Start/End data collection
- 2016 until 2025
- Design paper
- Early imaging biomarkers of lung cancer
- PID
- https://doi.org/10.34760/652667e86cd98
Population
- Countries
- Netherlands (the)
- Regions
- Drenthe, Friesland, Groningen
- Number of participants
- 12000
- Number of participants with samples
- 12000
- Population age groups
- Middle-aged (45-64 years), Aged (65+ years)
- Other inclusion criteria
- Completed second round Lifelines visit including lung function test
Organisations
Lead organisations
- University Medical Centre Groningen (UMCG)Netherlands (the)https://www.umcg.nl/
Additional organisations
- Siemens (Siemens)Netherlands (the)
Contributors
- Rozemarijn VliegenthartUniversity Medical Centre Groningenr.vliegenthart@umcg.nl
Principal Investigator
Available Data & Samples
Data categories
- Biological samples
- Imaging data
Subpopulations
List of subpopulations for this resource...
| Name | Description | Number of participants |
|---|
Collection events
List of collection events defined for this resource...
| Name | Description | Participants | Start end year |
|---|
Publications
Access conditions
Data access application via Lifelines and the PI...
- Data use conditions
- collaboration required
- Release type
- Periodically
- Linkage options
- Linkages via Lifelines
Funding & Acknowledgements
- Funding
- The ImaLife study is supported by an institutional research grant from Siemens Healthineers and by the Ministry of Economic Afairs and Climate Policy by means of the PPP Allowance made avail?able by the Top Sector Life Sciences & Health to stimulate public private partnership.
- Acknowledgements
- We would like to thank all participants and technicians of the ImaLife study and also the Lifelines personnel.